+ +

•  

   

     Western blot analysis using PDK1 mouse mAb against NIH/3T3 (1), Hela (2), Jurkat (3), HepG2 (4), PC-12 (5), and Cos7 (6) cell lysate.    

  
  

•  

   

     Immunofluorescence analysis of HELA cells using PDK1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.    

  
  

•  

   

     Flow cytometric analysis of Lovo cells using PDK1 mouse mAb (green) and negative control (purple).    

  
  

•  

   

     Immunohistochemical analysis of paraffin-embedded human breast cancer tissues (left) and brain tissues (right) using PDK1 mouse mAb with DAB staining.    

  
  

**Background of PDK1 Antibody**

The 3-phosphoinositide-dependent protein kinase 1 (PDK1) is a central regulator of cell growth, proliferation, and survival, primarily through its role in activating AGC kinase family members such as PKB/AKT, SGK, and PKC. As a key component of the PI3K/AKT/mTOR signaling pathway, PDK1 phosphorylates these downstream kinases at their activation loop, enabling their full enzymatic activity. Dysregulation of PDK1 is implicated in various diseases, including cancer, diabetes, and neurodegenerative disorders, making it a critical target for therapeutic and diagnostic research.

PDK1 antibodies are essential tools for studying its expression, localization, and function in cellular and disease contexts. They are widely used in techniques like Western blotting, immunohistochemistry, immunoprecipitation, and flow cytometry to assess PDK1 protein levels, phosphorylation status, or interactions with other signaling molecules. Researchers often utilize phospho-specific PDK1 antibodies (e.g., targeting Ser241. a critical autophosphorylation site) to study its activation dynamics.

The specificity and sensitivity of PDK1 antibodies depend on their epitope targets, with some designed to detect total PDK1 protein and others tailored for specific post-translational modifications or isoforms. Validated antibodies are crucial for ensuring accurate results, particularly in distinguishing PDK1 from homologous kinases. These reagents have advanced investigations into PI3K pathway signaling, drug resistance mechanisms, and the development of PDK1-targeted therapies, underscoring their importance in both basic and translational research.